The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
KPWHRI’s Michael L. Jackson, PhD, MPH, talks about influenza vaccine research in the age of the pandemic.
KPWHRI infectious disease expert Dr. Michael Jackson reports on the latest influenza news and how we’re learning to improve future predictions.
Parent volunteers who value immunization show promise as advocates to help protect communities against contagious diseases
Vaccine Treatment and Evaluation Unit tests real-world use to prepare for H7N9.
Vaccine Treatment and Evaluation Unit tests real-world use to prepare for H7N9.
Group Health, WithinReach, Seattle Children’s, BestStart, WA Dept of Health partnered.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.